Product NDC: | 16590-160 |
Proprietary Name: | NABUMETONE |
Non Proprietary Name: | NABUMETONE |
Active Ingredient(s): | 750 mg/1 & nbsp; NABUMETONE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16590-160 |
Labeler Name: | STAT RX USA LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076009 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030124 |
Package NDC: | 16590-160-56 |
Package Description: | 56 TABLET in 1 BOTTLE (16590-160-56) |
NDC Code | 16590-160-56 |
Proprietary Name | NABUMETONE |
Package Description | 56 TABLET in 1 BOTTLE (16590-160-56) |
Product NDC | 16590-160 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | NABUMETONE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20030124 |
Marketing Category Name | ANDA |
Labeler Name | STAT RX USA LLC |
Substance Name | NABUMETONE |
Strength Number | 750 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |